NAPSA explained

Napsin-A is an aspartic proteinase that is encoded in humans by the NAPSA gene.[1] The name napsin comes from novel aspartic proteinase of the pepsin family.[2]

The activation peptide of an aspartic proteinase acts as an inhibitor of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.[1]

Utility

Detection of NAPSA gene expression can be used to distinguish adenocarcinomas from other forms of lung cancer.[3]

Further reading

Notes and References

  1. Web site: Entrez Gene: NAPSA napsin A aspartic peptidase.
  2. Tatnell . Peter J . Powell . David J . Hill . Jeffrey . Smith . Trudi S . Tew . David G . Kay . John . Napsins: new human aspartic proteinases . FEBS Letters . 11 December 1998 . 441 . 1 . 43–48 . 10.1016/s0014-5793(98)01522-1 . 9877162. 27656626 .
  3. Ueno T, Linder S, Elmberger G . Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. . Br. J. Cancer . 88 . 8 . 1229–33 . 2004 . 10.1038/sj.bjc.6600879 . 12698189 . 2747556 .